XML 137 R51.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
COMMITMENTS AND CONTINGENCIES (Details Narrative)
 1 Months Ended 3 Months Ended 12 Months Ended
Feb. 24, 2024
USD ($)
Jan. 26, 2024
USD ($)
shares
Aug. 22, 2023
USD ($)
Jun. 26, 2023
shares
Jun. 02, 2023
shares
May 23, 2023
shares
Oct. 06, 2022
USD ($)
Oct. 03, 2022
USD ($)
Mar. 31, 2021
USD ($)
Apr. 28, 2019
USD ($)
Jan. 04, 2018
USD ($)
$ / shares
shares
Jun. 30, 2012
Mar. 31, 2024
USD ($)
shares
Dec. 31, 2023
USD ($)
shares
Dec. 31, 2022
USD ($)
shares
Mar. 31, 2024
ILS (₪)
Feb. 24, 2024
ILS (₪)
Dec. 31, 2023
ILS (₪)
Dec. 11, 2022
USD ($)
Dec. 11, 2022
ILS (₪)
Jun. 10, 2021
USD ($)
Loss Contingencies [Line Items]                                          
Royalties payable as percentage of future sales                         3.00% 3.00%              
Gross proceeds from cash fee percentage               7.00%                          
Gross proceeds from management fee percentage               1.00%                          
Stock Issued During Period, Value, New Issues                         $ 2,397,000 [1] $ 6,558,000 [2] $ 4,324,000 [3]            
Litigation Settlement, Amount Awarded to Other Party   $ 2,154,000                                      
[custom:SettlementAgreementLiability-0]                           2,211,000              
[custom:InsuranceRecoverable-0]                           1,335,000              
Loss Contingency, Receivable                           1,100,000              
Legal Fees                           235,000              
Gain (Loss) from Litigation Settlement                           1,111,000            
Common Stock [Member]                                          
Loss Contingencies [Line Items]                                          
Stock Issued During Period, Value, New Issues                         $ 17,000 [1] $ 38,000 [2] $ 8,000 [3]            
Stock Issued During Period, Shares, New Issues | shares                         1,685,682 [1] 3,816,689 [2] 782,495 [3]            
Joseph Mona [Member]                                          
Loss Contingencies [Line Items]                                          
Loss Contingency, Damages Sought, Value     $ 485,000           $ 485,000                        
Chief Executive Officer [Member]                                          
Loss Contingencies [Line Items]                                          
[custom:ContigentBonus-0] $ 298,000                                        
Other Commitments, Description The first 50% of the CEO’s contingent bonus ($149) is payable upon the Company raising at least $3,000 in new funds by June 30, 2024. The remaining 50% ($149), payable upon the Company raising at least $6,000 in new funds by September 30, 2024 (cumulative, so if $3,000 is not raised by June 30, 2024 but the full $6,000 is raised by September 30, 2024, the full amount is payable).                                        
Other Executives [Member]                                          
Loss Contingencies [Line Items]                                          
[custom:ContigentBonus-0] $ 60,000                               ₪ 230,736        
Other Commitments, Description which is payable upon the Company raising at least $3,000 in new funds by September 30, 2024.                                        
Device [Member]                                          
Loss Contingencies [Line Items]                                          
Royalties percent             3.00%                            
Integrated Product [Member]                                          
Loss Contingencies [Line Items]                                          
Royalties percent             1.50%                            
Securities Purchase Agreement [Member]                                          
Loss Contingencies [Line Items]                                          
Loss Contingency, Damages Sought, Value                         $ 6,750,000 $ 6,750,000              
Securities Purchase Agreement [Member] | Common Stock [Member]                                          
Loss Contingencies [Line Items]                                          
Stock Issued During Period, Shares, New Issues | shares       624,618 701,756 975,000                              
Litigation Settlement [Member]                                          
Loss Contingencies [Line Items]                                          
Payments for Legal Settlements   $ 1,100,000                     1,100,000                
Stock Issued During Period, Shares, Restricted Stock Award, Gross | shares   1,005,965                                      
[custom:InsuranceRecoveryAmount]                         $ 1,335,000                
Litigation Settlement [Member] | Common Stock [Member]                                          
Loss Contingencies [Line Items]                                          
Stock Issued During Period, Shares, New Issues | shares                         1,005,965                
Israeli Innovation Authority [Member]                                          
Loss Contingencies [Line Items]                                          
Grants Receivable                         $ 74,000 304       ₪ 27,000 $ 83,000 ₪ 300,000  
[custom:AdditionalGrantReceivable-0]                         $ 447,000 $ 447   ₪ 1,620,000   ₪ 1,620,000      
Israeli Innovation Authority [Member] | Minimum [Member]                                          
Loss Contingencies [Line Items]                                          
Royalties payable as percentage of future sales                         3.00% 3.00%              
Israeli Innovation Authority [Member] | Maximum [Member]                                          
Loss Contingencies [Line Items]                                          
Royalties payable as percentage of future sales                         5.00% 5.00%              
Israeli Innovation Authority [Member] | CardioSert Ltd [Member]                                          
Loss Contingencies [Line Items]                                          
Repayment of government grants                     $ 530,000                    
Israeli Innovation Authority [Member] | Nitiloop [Member]                                          
Loss Contingencies [Line Items]                                          
Repayment of government grants             $ 925,000                            
Technion Research and Development Foundation Limited [Member] | Minimum [Member]                                          
Loss Contingencies [Line Items]                                          
Royalties payable as percentage of future sales                       1.50%                  
Technion Research and Development Foundation Limited [Member] | Maximum [Member]                                          
Loss Contingencies [Line Items]                                          
Royalties payable as percentage of future sales                       3.00%                  
CardioSert Ltd [Member] | Technology [Member]                                          
Loss Contingencies [Line Items]                                          
Payments to Acquire Intangible Assets                     $ 300,000                    
Stock Issued During Period, Shares, Acquisitions | shares                     6,738                    
Stock Issued During Period, Value, Acquisitions                     $ 74,000                    
Buy back amount per patent | $ / shares                     $ 1.00                    
Consulting fee description                     Additionally, the CardioSert Agreement may be terminated by either party upon breach of the other (subject to cure). Until May 2023, Microbot Israel paid CardioSert a monthly consultation fee of NIS                    
Professional Fees                     $ 40,000,000                    
Monthly consultation fee in USD | $ / shares                     $ 11                    
Currency exchange rate, description                     exchange rate of NIS 3.7 to the dollar)                    
CardioSert Ltd [Member] | Minimum [Member] | Technology [Member]                                          
Loss Contingencies [Line Items]                                          
Investments                     $ 2,000,000                    
H.C. Wainwright & Co. LLC [Member]                                          
Loss Contingencies [Line Items]                                          
Professional Fees               $ 565,000                          
Warrant or Right, Reason for Issuance, Description               The Company has also agreed to issue to Wainwright or its designees preferred investment options upon the closing of such offerings, equal to five (5.0%) percent of the aggregate number of such shares of common stock in such offerings, including upon exercise for cash of any warrants issued to investors in such offering.                          
H.C. Wainwright & Co. LLC [Member] | At-the-Market Offering Agreement [Member]                                          
Loss Contingencies [Line Items]                                          
Offering costs                                         $ 10,000,000
Stock Issued During Period, Value, New Issues             $ 8,000,000                            
H.C. Wainwright & Co. LLC [Member] | Securities Purchase Agreement [Member] | Common Stock [Member]                                          
Loss Contingencies [Line Items]                                          
Stock Issued During Period, Shares, New Issues | shares       31,231                                  
Alliance Investment Management, Ltd. [Member]                                          
Loss Contingencies [Line Items]                                          
Litigation Settlement, Amount Awarded from Other Party                   $ 468,000                      
Ministry of Economy [Member]                                          
Loss Contingencies [Line Items]                                          
Grants Receivable                         $ 50,000                
2013 Through June 30, 2022 [Member] | Israeli Innovation Authority [Member]                                          
Loss Contingencies [Line Items]                                          
Revenue from Contract with Customer, Including Assessed Tax                           $ 1,804,000              
2013 through March 31, 2024 [Member] | Israeli Innovation Authority [Member]                                          
Loss Contingencies [Line Items]                                          
Revenue from Contract with Customer, Including Assessed Tax                         $ 1,878,000                
[1] Net of issuance costs in the amount of $
[2] Net of issuance costs in the amount of $
[3] Net of issuance costs in the amount of $